About article
Development and validation of patient decision aid for antidepressant medications
Objectives: to develop and validate a decision aids to use in shared decision-making fro Arabic depressed patients. Methods: A six-page DA booklet published by Agency for Health Care Research and Quality (AHRQ) was adapted and translated to Arabic using Brisling's back translation model. The work of Al-Muhtaseb was followed to produce a natural Arabic text. Validation was carried out by 24 experts (Physicians, Pharmacists, Academic staff and depressed Patients). International Patient Decision Aid Standards (IPDAS) Criteria Checklist was used to examine the DA structure and content. Results: Experts strongly agree that the DA will increase patient's recognition, knowledge and understanding of their condition and options, based on (IPDAS). 83% of experts report that DA provide information about options in sufficient detail for decision making, 68% present probabilities of outcomes is an unbiased and understandable way, 85% clarifying and expressing patients values and 87% for structure guidance in deliberation and communication with a total of 81% for the whole content criteria. Secondly, the development process has 63% positive feedback. Particularly, 83% agreed that the information are present in balanced manner, 65% for having a systematic development process, 71% for using a scientific evidence data , 69% for using plain language but less than half of the experts agreed with the disclosing conflicts of interest. Finally, the sum of expected effectiveness criteria got a very high percentage (93%). In addition, experts provided constructive feedback with some modification regarding the language and general layout of the DA Conclusions: Up to our knowledge we developed and validated the first Arabic DA based on IPDAS criteria for depressed patients. Future research needed to assess the effectiveness of this DA on depressed patient involvement in SDM.
Al Jumah, K. (2016). "Development and validation of patient decision aid for antidepressant medications." Value in Health 19(3): A18-A19.
Methods | Condition | Gender | Age | Country | Setting | Sample size |
---|---|---|---|---|---|---|
|
o |
Kuwait |
Measure does not require training
Not available